All Stories

  1. Third-Generation Trabecular Micro-Bypass Implantation and Phacoemulsification in Patients with Glaucoma: A Multicenter Study

    Article • Vision, July 2025, MDPI AG

    Founder and CEO Steven R Sarkisian, MD

  2. Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty

    Article • American Journal of Ophthalmology, April 2025, Elsevier

    Founder and CEO Steven R Sarkisian, MD

  3. Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY Study

    Article • Ophthalmology and Therapy, March 2025, Springer Science + Business Media

    Founder and CEO Steven R Sarkisian, MD

  4. Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials

    Article • Drugs, September 2024, Springer Science + Business Media

    Founder and CEO Steven R Sarkisian, MD

  5. Standalone Interventional Glaucoma: An Evolution from the Combination-Cataract Paradigm

    Article • Journal of Cataract & Refractive Surgery, August 2024, Wolters Kluwer Health

    Founder and CEO Steven R Sarkisian, MD

  6. Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial

    Article • Ophthalmology and Therapy, February 2024, Springer Science + Business Media

    Founder and CEO Steven R Sarkisian, MD

  7. Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

    Article • Drugs, December 2023, Springer Science + Business Media

    Founder and CEO Steven R Sarkisian, MD

  8. Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: Interim Results from the GEMINI Study

    Article • Clinical Ophthalmology, February 2021, Taylor & Francis

    Founder and CEO Steven R Sarkisian, MD

  9. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

    Article • Ophthalmology, June 2019, Elsevier

    Founder and CEO Steven R Sarkisian, MD

  10. 360° ab-interno trabeculotomy in refractory primary open-angle glaucoma

    Article • Clinical Ophthalmology, January 2019, Dove Medical Press

    Basil Mathews, Founder and CEO Steven R Sarkisian, MD

  11. July consultation #5

    Article • Journal of Cataract & Refractive Surgery, July 2017, Wolters Kluwer Health

    Founder and CEO Steven R Sarkisian, MD

  12. 32 Canaloplasty

    Article • January 2017, Thieme Publishing Group

    Founder and CEO Steven R Sarkisian, MD

  13. 36 Endoscopic Cyclophotocoagulation

    Article • January 2017, Thieme Publishing Group

    Founder and CEO Steven R Sarkisian, MD

  14. 28 Trabecular Bypass: iStent

    Article • January 2017, Thieme Publishing Group

    Founder and CEO Steven R Sarkisian, MD

  15. Minimally Invasive Glaucoma Surgery

    Article • January 2017, Thieme Publishing Group

    Founder and CEO Steven R Sarkisian, MD

  16. 27 360-Degree Ab Interno Trabeculotomy

    Article • January 2017, Thieme Publishing Group

    Founder and CEO Steven R Sarkisian, MD

  17. July consultation #5

    Article • Journal of Cataract & Refractive Surgery, July 2015, Wolters Kluwer Health

    Founder and CEO Steven R Sarkisian, MD

  18. Ab interno approach to the suprachoroidal space

    Article • Journal of Cataract & Refractive Surgery, August 2014, Wolters Kluwer Health

    Founder and CEO Steven R Sarkisian, MD

  19. Tube shunt complications and their prevention

    Article • Current Opinion in Ophthalmology, March 2009, Wolters Kluwer Health

    Founder and CEO Steven R Sarkisian, MD